Chen, L., Cai, H., Lu, J., Niu, T., Gao, N., Zhang, Z., Fang, B., Yan, Z., Tan, K., Liang, R., Zhang, W. (2026). Initial phase 1b/2 study results of purinostat mesylate (PM) in combination with pomalidomide (POM) and low dexamethasone (DEX) in patients with RRMM.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.tps7581